Scholars@Duke

NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021.

Publication ,  Journal Article
Swetter, SM; Thompson, JA; Albertini, MR; Barker, CA; Baumgartner, J; Boland, G; Chmielowski, B; DiMaio, D; Durham, A; Fields, RC; Fleming, MD ...
Published in: J Natl Compr Canc Netw
April 1, 2021
Published version (DOI) Link to item

Over the past few years, the NCCN Guidelines for Melanoma: Cutaneous have been expanded to include pathways for treatment of microscopic satellitosis (added in v2.2020), and the following Principles sections: Molecular Testing (added in v2.2019), Systemic Therapy Considerations (added in v2.2020), and Brain Metastases Management (added in v3.2020). The v1.2021 update included additional modifications of these sections and notable revisions to Principles of: Pathology, Surgical Margins for Wide Excision of Primary Melanoma, Sentinel Lymph Node Biopsy, Completion/Therapeutic Lymph Node Dissection, and Radiation Therapy. These NCCN Guidelines Insights discuss the important changes to pathology and surgery recommendations, as well as additions to systemic therapy options for patients with advanced disease.

Duke Scholars

April Kelly Scott Salama
Author April Kelly Scott Salama Medicine, Medical Oncology
Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

10.6004/jnccn.2021.0018

EISSN

1540-1413

Publication Date

April 1, 2021

Volume

19

Issue

4

Start / End Page

364 / 376

Location

United States

Related Subject Headings

  • Skin Neoplasms
  • Sentinel Lymph Node Biopsy
  • Oncology & Carcinogenesis
  • Melanoma
  • Lymph Node Excision
  • Humans
  • Brain Neoplasms
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Swetter, S. M., Thompson, J. A., Albertini, M. R., Barker, C. A., Baumgartner, J., Boland, G., … Engh, A. M. (2021). NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021. J Natl Compr Canc Netw, 19(4), 364–376. https://doi.org/10.6004/jnccn.2021.0018
Swetter, Susan M., John A. Thompson, Mark R. Albertini, Christopher A. Barker, Joel Baumgartner, Genevieve Boland, Bartosz Chmielowski, et al. “NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021.” J Natl Compr Canc Netw 19, no. 4 (April 1, 2021): 364–76. https://doi.org/10.6004/jnccn.2021.0018.
Swetter SM, Thompson JA, Albertini MR, Barker CA, Baumgartner J, Boland G, et al. NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021. J Natl Compr Canc Netw. 2021 Apr 1;19(4):364–76.
Swetter, Susan M., et al. “NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021.” J Natl Compr Canc Netw, vol. 19, no. 4, Apr. 2021, pp. 364–76. Pubmed, doi:10.6004/jnccn.2021.0018.
Swetter SM, Thompson JA, Albertini MR, Barker CA, Baumgartner J, Boland G, Chmielowski B, DiMaio D, Durham A, Fields RC, Fleming MD, Galan A, Gastman B, Grossmann K, Guild S, Holder A, Johnson D, Joseph RW, Karakousis G, Kendra K, Lange JR, Lanning R, Margolin K, Olszanski AJ, Ott PA, Ross MI, Salama AK, Sharma R, Skitzki J, Sosman J, Wuthrick E, McMillian NR, Engh AM. NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021. J Natl Compr Canc Netw. 2021 Apr 1;19(4):364–376.

Published In

J Natl Compr Canc Netw

DOI

10.6004/jnccn.2021.0018

EISSN

1540-1413

Publication Date

April 1, 2021

Volume

19

Issue

4

Start / End Page

364 / 376

Location

United States

Related Subject Headings

  • Skin Neoplasms
  • Sentinel Lymph Node Biopsy
  • Oncology & Carcinogenesis
  • Melanoma
  • Lymph Node Excision
  • Humans
  • Brain Neoplasms
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis